Skip to main content

Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon/Ribavirin Therapy

  • Conference paper
Knowledge, Information, and Creativity Support Systems

Part of the book series: Lecture Notes in Computer Science ((LNAI,volume 6746))

  • 722 Accesses

Abstract

Less than a half of hepatitis C patients respond to the current therapy by peg-interferon combined with ribavirin, and the genomic basis of those drug resistance remains unknown. It is recognized that the emerging challenge in the development of therapies for hepatitis C is new functions and mysteries of hepatitis C virus (HCV) non structural 5A (NS5A) protein. Different from current studies using small experimental samples to analyze relations between the HCV NS5A region and the response to interferon/ribavirin therapy, we introduce a data mining-based framework that exploits the largest available HCV database. This paper focuses on the methodology and early results of analyzing NS5A data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Murray, P.R., Rosenthal, K.S., Pfaller, M.A.: Medical Microbiology, Ch. 66. Mosby Philadelphia (2009)

    Google Scholar 

  2. Gao, M., Nettles, R.E., et al.: Chemical genetics strategy identifies an hcv ns5a inhibitor with a potent clinical effect. Nature 465, 953–960 (2010)

    Google Scholar 

  3. Lemon, S.M., Keating, J.A., Pietschmannc, T., Frickd, D.N., Glenne, J.S., Tellinghuisenf, T.L., Symonsg, J., Furman, P.A.: Development of novel therapies for hepatitis c. Antiviral Research 86, 79–92 (2010)

    Article  Google Scholar 

  4. Jardim, A.C.G., Yamasaki, L.H.T., Queiro, A.T.L., Bittar, C., Rahal, R.P.R., de Carvalho Mello, I.M.V.: Quasispecies of hepatitis c virus genotype 1 and treatment outcome with peginterferon and ribavirin. Infection, Genetics and Evolution 9, 689–698 (2009)

    Article  Google Scholar 

  5. Aurora, R., Donlin, M.J., Cannon, N.A.: Genome-wide hepatitis c virus amino acid covariance networks can predict response to antiviral therapy in humans. The Journal of Clinical Investigation 119, 225–236 (2009)

    Google Scholar 

  6. Feld, J.J., Hoofnagle, J.H.: Mechanism of action of interferon and ribavirin in treatment of hepatitis c. Nature 436, 967–972 (2005)

    Article  Google Scholar 

  7. Enomoto, N., Maekawa, S.: Hcv genetic elements determining the early response to peginterferon and ribavirin therapy. Intervirology 334, 77–81 (2010)

    Google Scholar 

  8. Francessco, R., Migliaccio, G.: Challenges and successes in developing new therapies for hepatitis c. Nature 436, 96–100 (2005)

    Google Scholar 

  9. Guillou-Guillemette, H.L., Vallet, S., Gaudy-Graffin, C., Payan, C., Pivert, A., Goudeau, A., Lunel-Fabiani, F.: Genetic diversity of the hepatitis c virus: Impact and issues in the antiviral therapy. World Journal of Gastroenterology 13(17), 2416–2426 (2007)

    Article  Google Scholar 

  10. AlHefnawi, M.M., Zada, S., El-Azab, I.A.: Prediction of prognostic biomarker for interferon-based therapy to hepatitis c virus patients: a metaanalysis of the ns5a protein in subtypes 1a, 1b, and 3a. Virology Journal 7, 1–9 (2010)

    Article  Google Scholar 

  11. Macdonaldt, A., Harris, M.: Hepatitis c virus ns5a: Tales of a promiscuous protein. Journal of General Virology 85, 2485–2502 (2004)

    Article  Google Scholar 

  12. Wohnsland, A., Hofmann, W.P., Sarrazin, C.: Viral determinants of resistance to treatment in patients with hepatitis c. Clinical Microbiology Reviews, 20 (2007)

    Google Scholar 

  13. Sharma, S.D.: Hepatitis c virus: Molecular biology & current therapetic options. Indian Journal of Medical Research 131, 17–34 (2010)

    Google Scholar 

  14. Kamal, S.M.: Acute hepatitis c: a systematic review. The American Journal of Gastroenterology 103(5), 1283–1297 (2008)

    Article  Google Scholar 

  15. Kuiken, C., Yusim, K., Boykin, L., Richardson, R.: The los alamos hepatitis c sequence database. Bioinformatics 21(3), 379–384 (2005)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kawasaki, S., Ho, T.B., Kanda, T., Yokosuka, O., Takabayashi, K., Le, N. (2011). Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon/Ribavirin Therapy. In: Theeramunkong, T., Kunifuji, S., Sornlertlamvanich, V., Nattee, C. (eds) Knowledge, Information, and Creativity Support Systems. Lecture Notes in Computer Science(), vol 6746. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24788-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-24788-0_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-24787-3

  • Online ISBN: 978-3-642-24788-0

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics